HK1172649A1 - Improved human long pentraxin expression system and uses thereof - Google Patents

Improved human long pentraxin expression system and uses thereof

Info

Publication number
HK1172649A1
HK1172649A1 HK12113464.6A HK12113464A HK1172649A1 HK 1172649 A1 HK1172649 A1 HK 1172649A1 HK 12113464 A HK12113464 A HK 12113464A HK 1172649 A1 HK1172649 A1 HK 1172649A1
Authority
HK
Hong Kong
Prior art keywords
expression system
improved human
human long
long pentraxin
pentraxin
Prior art date
Application number
HK12113464.6A
Other languages
English (en)
Chinese (zh)
Inventor
.薩薩諾
.埃斯普斯托
.瑞維希奧
.卡薩尼
Original Assignee
希格馬托製藥工業公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 希格馬托製藥工業公司 filed Critical 希格馬托製藥工業公司
Publication of HK1172649A1 publication Critical patent/HK1172649A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/50Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
HK12113464.6A 2009-07-29 2012-12-27 Improved human long pentraxin expression system and uses thereof HK1172649A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09166759 2009-07-29
PCT/EP2010/060469 WO2011012496A1 (en) 2009-07-29 2010-07-20 Improved human long pentraxin 3 expression system and uses thereof

Publications (1)

Publication Number Publication Date
HK1172649A1 true HK1172649A1 (en) 2013-04-26

Family

ID=41120115

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12113464.6A HK1172649A1 (en) 2009-07-29 2012-12-27 Improved human long pentraxin expression system and uses thereof

Country Status (23)

Country Link
US (1) US8883446B2 (es)
EP (1) EP2459721B1 (es)
JP (1) JP5859963B2 (es)
KR (1) KR101767695B1 (es)
CN (1) CN102549160B (es)
AU (1) AU2010277786B2 (es)
BR (1) BR112012001980A2 (es)
CA (1) CA2769257C (es)
CY (1) CY1116486T1 (es)
DK (1) DK2459721T3 (es)
EA (1) EA023191B1 (es)
ES (1) ES2432242T3 (es)
HK (1) HK1172649A1 (es)
HR (1) HRP20130947T1 (es)
IL (1) IL217696A (es)
ME (1) ME01566B (es)
MX (1) MX2012001109A (es)
PL (1) PL2459721T3 (es)
PT (1) PT2459721E (es)
RS (1) RS53006B (es)
SG (1) SG177756A1 (es)
SI (1) SI2459721T1 (es)
WO (1) WO2011012496A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206433B2 (en) * 2013-05-01 2015-12-08 Dna Twopointo, Inc. Methods, compositions and kits for a one-step DNA cloning system
US10253321B2 (en) 2013-05-01 2019-04-09 Dna2.0, Inc. Methods, compositions and kits for a one-step DNA cloning system
TWI528969B (zh) * 2013-06-07 2016-04-11 國立成功大學 胺基酸序列用於製備抑制ptx3治療鼻咽癌之醫藥組合物之用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298487B1 (it) 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
JP4554370B2 (ja) * 2002-03-29 2010-09-29 ゾーマ テクノロジー リミテッド 多重遺伝子プラスミドおよび組み換えポリペプチドの発現増加法
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
WO2009095403A1 (en) * 2008-01-29 2009-08-06 Tecnogen S.P.A. Expression system and uses thereof for the production of human long pentraxin 3

Also Published As

Publication number Publication date
RS53006B (en) 2014-04-30
CN102549160A (zh) 2012-07-04
US20120301873A1 (en) 2012-11-29
HRP20130947T1 (hr) 2013-11-08
KR20120047259A (ko) 2012-05-11
ME01566B (me) 2014-09-20
AU2010277786A1 (en) 2012-03-01
CY1116486T1 (el) 2017-03-15
PT2459721E (pt) 2013-10-31
DK2459721T3 (da) 2013-11-04
WO2011012496A1 (en) 2011-02-03
ES2432242T3 (es) 2013-12-02
JP5859963B2 (ja) 2016-02-16
JP2013504304A (ja) 2013-02-07
IL217696A (en) 2017-06-29
CA2769257C (en) 2017-12-05
SG177756A1 (en) 2012-02-28
KR101767695B1 (ko) 2017-08-11
SI2459721T1 (sl) 2013-11-29
PL2459721T3 (pl) 2014-01-31
AU2010277786B2 (en) 2016-04-14
CN102549160B (zh) 2014-04-02
EA023191B1 (ru) 2016-05-31
EP2459721A1 (en) 2012-06-06
BR112012001980A2 (pt) 2015-09-01
CA2769257A1 (en) 2011-02-03
US8883446B2 (en) 2014-11-11
EP2459721B1 (en) 2013-09-18
MX2012001109A (es) 2012-03-26
EA201200198A1 (ru) 2012-06-29

Similar Documents

Publication Publication Date Title
IL241745A (en) Imaging system and techniques
PL2414015T4 (pl) System laryngoskopowy
HRP20181973T1 (hr) Poboljšana anti humana fraktalkinska protutijela i njihova uporaba
PT2421582T (pt) Dispositivo funcional externo, aparelho de tratamento de sangue para receber um dispositivo funcional externo de acordo com a presente invenção, assim como processos
HUE056076T2 (hu) Szívsegítõ készülék és rendszer
EP2498853A4 (en) PATIENT INTERFACE AND ITS ASPECTS
EP2429623A4 (en) PATIENT INTERFACE AND CORRESPONDING ASPECTS
EP2383283A4 (en) NOGGIN PEPTIDE AND ITS USE
EP2474555A4 (en) PEPTIDE DERIVED FROM WNT10 AND USE THEREOF
HK1151598A1 (en) Systems and methods for sensing human actions via networks
PT2563806E (pt) Leucolectinas humanas e suas utilizações
PL2486519T3 (pl) System bezpieczeństwa i przetrwania ludzi
HK1172649A1 (en) Improved human long pentraxin expression system and uses thereof
GB0905970D0 (en) Depsipeptides and their therapeutic use
EP2450374A4 (en) PEPTIDE AND ITS USE
AP3351A (en) Extracellular plant ferredoxin-like protein and uses thereof
GB0906806D0 (en) Enhanced human figure display system
LT2349383T (lt) Širdies pagalbinis prietaisas ir sistema

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190723